A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 9,706 shares of CRL stock, worth $1.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,706
Previous 9,631 0.78%
Holding current value
$1.93 Million
Previous $2.61 Million 23.15%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$206.39 - $268.73 $15,479 - $20,154
75 Added 0.78%
9,706 $2.01 Million
Q1 2024

May 06, 2024

BUY
$203.52 - $273.43 $40,704 - $54,686
200 Added 2.12%
9,631 $2.61 Million
Q4 2023

Feb 07, 2024

SELL
$164.52 - $238.84 $12,174 - $17,674
-74 Reduced 0.78%
9,431 $2.23 Million
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $1.85 Million - $2.07 Million
9,505 New
9,505 $1.86 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Envestnet Portfolio Solutions, Inc. Portfolio

Follow Envestnet Portfolio Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Portfolio Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Portfolio Solutions, Inc. with notifications on news.